CRRX — CareRx Cashflow Statement
0.000.00%
Last trade - 00:00- CA$233.69m
- CA$306.87m
- CA$366.71m
- 68
- 58
- 73
- 74
Annual cashflow statement for CareRx, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.3 | -22.7 | -34.4 | -5.41 | -4.5 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5.09 | 18.6 | 35.5 | 9.44 | 14.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.94 | -3.96 | 1.13 | 3.36 | 9.18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.229 | 7.27 | 22.3 | 27.4 | 38 |
| Capital Expenditures | -1.96 | -7.12 | -13.6 | -8.7 | -8.11 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.22 | -86.1 | -2.98 | -3.62 | 0.196 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.17 | -93.2 | -16.6 | -12.3 | -7.92 |
| Financing Cash Flow Items | 4.97 | -9.3 | -8.71 | -11.2 | -5.63 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.5 | 102 | -13 | -36.4 | -28 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.6 | 16 | -7.25 | -21.3 | 2.06 |